20/01/2026
TRIAL OPPORTUNITY: Advanced or Metastatic Non squamous Non-Small Cell Lung Cancer.
We are running study that will be testing a new medicine called ABP 234 against a known cancer drug, Keytruda® (Pembrolizumab), to see how well they work for people with advanced non-small cell lung cancer that has spread.
It’s a ‘randomized, double-blind’ trial, which means participants are randomly assigned one of the drugs, and neither you nor the doctors will know which one you’re getting—this helps make the results fair.
We’re looking at how effective they are, how the body handles them, and how safe they are.
Joining could mean trying a new option while helping us improve cancer care!
Contact Rainbow Research on trials@rainbowoncology.co.za or +27 31 904 1840